Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.
about
Pharmacological treatment of Parkinson's disease.Continuous drug delivery in Parkinson's disease.The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's diseaseEntacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month studyHealth-related quality of life as an outcome variable in Parkinson's disease.Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease.
P2860
Q34048261-DA0B58A4-5194-4D86-BA7A-659640195DBBQ34390800-12415D80-B3B7-4A51-A18C-0E4FC1092B1AQ35456745-FACA239D-D930-4BF3-B260-ABBFB377A941Q35475549-7C6CDB94-D41B-4A67-ACB6-17CBA932462AQ35825918-74C7F8B7-4865-4349-AE49-6B861775450FQ37115650-80E0685B-CC33-45D0-B39B-73B9DA393469Q53524831-5782BDDF-766E-48A4-BBA8-EAF4B3124499
P2860
Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Comparison of standard carbido ...... and quality-of-life measures.
@en
Comparison of standard carbido ...... and quality-of-life measures.
@nl
type
label
Comparison of standard carbido ...... and quality-of-life measures.
@en
Comparison of standard carbido ...... and quality-of-life measures.
@nl
prefLabel
Comparison of standard carbido ...... and quality-of-life measures.
@en
Comparison of standard carbido ...... and quality-of-life measures.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of standard carbido ...... and quality-of-life measures.
@en
P2093
Robischon M
Silverstein P
P2860
P304
P356
10.1002/MDS.870120508
P407
P577
1997-09-01T00:00:00Z